Case Study: Novartis accelerates adverse drug reaction detection with DevsData’s AI and Big Data solution

Novartis detects adverse drug reactions 60% faster with DevsData

Novartis, a global pharmaceutical company, struggled to efficiently detect adverse drug reactions (ADRs) buried within vast amounts of unstructured social media data using their traditional pharmacovigilance systems. They partnered with the vendor DevsData to develop an AI and NLP-driven solution to address this challenge and accelerate safety signal detection.

DevsData implemented a scalable, AI-powered system that processed social media data in real time to identify ADRs. The solution delivered by DevsData enabled Novartis to surface adverse drug reactions 60% faster than their previous methods and reduced manual data review time by 40%, significantly improving patient safety monitoring and operational efficiency.

Novartis